212 related articles for article (PubMed ID: 20800322)
1. Synthesis, biological assay in vitro and molecular docking studies of new imidazopyrazinone derivatives as potential dipeptidyl peptidase IV inhibitors.
Zhu Y; Xia S; Zhu M; Yi W; Cheng J; Song G; Li Z; Lu P
Eur J Med Chem; 2010 Nov; 45(11):4953-62. PubMed ID: 20800322
[TBL] [Abstract][Full Text] [Related]
2. (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Kim D; Wang L; Beconi M; Eiermann GJ; Fisher MH; He H; Hickey GJ; Kowalchick JE; Leiting B; Lyons K; Marsilio F; McCann ME; Patel RA; Petrov A; Scapin G; Patel SB; Roy RS; Wu JK; Wyvratt MJ; Zhang BB; Zhu L; Thornberry NA; Weber AE
J Med Chem; 2005 Jan; 48(1):141-51. PubMed ID: 15634008
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of structurally constrained imidazolidin derivatives as potent dipeptidyl peptidase IV inhibitors.
Wang L; Zhang B; Ji J; Li B; Yan J; Zhang W; Wu Y; Wang X
Eur J Med Chem; 2009 Aug; 44(8):3318-22. PubMed ID: 19375196
[TBL] [Abstract][Full Text] [Related]
4. Discovery of β-aminoacyl containing thiazolidine derivatives as potent and selective dipeptidyl peptidase IV inhibitors.
Park WS; Kang SK; Jun MA; Shin MS; Kim KY; Rhee SD; Bae MA; Kim MS; Kim KR; Kang NS; Yoo SE; Lee JO; Song DH; Silinski P; Schneider SE; Ahn JH; Kim SS
Bioorg Med Chem Lett; 2011 Mar; 21(5):1366-70. PubMed ID: 21306895
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
Sharma M; Gupta M; Singh D; Kumar M; Kaur P
Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y
Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, evaluation and molecular docking of prolyl-fluoropyrrolidine derivatives as dipeptidyl peptidase IV inhibitors.
Sharma M; Gupta M; Singh D; Kumar M; Kaur P
Chem Biol Drug Des; 2013 Aug; 82(2):156-66. PubMed ID: 23581745
[TBL] [Abstract][Full Text] [Related]
8. (3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Nitta A; Fujii H; Sakami S; Nishimura Y; Ohyama T; Satoh M; Nakaki J; Satoh S; Inada C; Kozono H; Kumagai H; Shimamura M; Fukazawa T; Kawai H
Bioorg Med Chem Lett; 2008 Oct; 18(20):5435-8. PubMed ID: 18819797
[TBL] [Abstract][Full Text] [Related]
9. Rational design and synthesis of potent and long-lasting glutamic acid-based dipeptidyl peptidase IV inhibitors.
Tsai TY; Hsu T; Chen CT; Cheng JH; Chiou MC; Huang CH; Tseng YJ; Yeh TK; Huang CY; Yeh KC; Huang YW; Wu SH; Wang MH; Chen X; Chao YS; Jiaang WT
Bioorg Med Chem Lett; 2009 Apr; 19(7):1908-12. PubMed ID: 19269819
[TBL] [Abstract][Full Text] [Related]
10. [Design, synthesis and in vitro activity of glycinamide-bearing compounds as DPP-IV inhibitors].
Han B; Huan Y; Lin ZY; Li P; Shen ZF; Yin DL; Huang HH
Yao Xue Xue Bao; 2010 Nov; 45(11):1379-84. PubMed ID: 21361038
[TBL] [Abstract][Full Text] [Related]
11. Discovering novel α-aminoacyl-containing proline derivatives with potent and selective inhibitory activity against dipeptidyl peptidase IV: design, synthesis, biological evaluation, and molecular modeling.
Zhang X; Wang J; Su M; Li Z; Li J; Li J; Liu H
Chem Biol Drug Des; 2012 Dec; 80(6):843-52. PubMed ID: 22726613
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Wu Y; Wu H; Tang L; Wu P; Liu T; Hu Y
Chem Biol Drug Des; 2013 Aug; 82(2):140-6. PubMed ID: 23530834
[TBL] [Abstract][Full Text] [Related]
13. A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors.
Lu IL; Tsai KC; Chiang YK; Jiaang WT; Wu SH; Mahindroo N; Chien CH; Lee SJ; Chen X; Chao YS; Wu SY
Eur J Med Chem; 2008 Aug; 43(8):1603-11. PubMed ID: 18207285
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine.
Al-masri IM; Mohammad MK; Tahaa MO
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1061-6. PubMed ID: 19640223
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV.
Zhang Z; Wallace MB; Feng J; Stafford JA; Skene RJ; Shi L; Lee B; Aertgeerts K; Jennings A; Xu R; Kassel DB; Kaldor SW; Navre M; Webb DR; Gwaltney SL
J Med Chem; 2011 Jan; 54(2):510-24. PubMed ID: 21186796
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group.
Kondo T; Nekado T; Sugimoto I; Ochi K; Takai S; Kinoshita A; Hatayama A; Yamamoto S; Kishikawa K; Nakai H; Toda M
Bioorg Med Chem; 2008 Feb; 16(4):1613-31. PubMed ID: 18039579
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Mo DW; Dong S; Sun H; Chen JS; Pang JX; Xi BM; Chen WH
Bioorg Med Chem Lett; 2015 May; 25(9):1872-5. PubMed ID: 25838146
[TBL] [Abstract][Full Text] [Related]
18. Novel N-substituted 4-hydrazino piperidine derivative as a dipeptidyl peptidase IV inhibitor.
Gupta RC; Chhipa L; Mandhare AB; Zambad SP; Chauthaiwale V; Nadkarni SS; Dutt C
Bioorg Med Chem Lett; 2009 Sep; 19(17):5021-5. PubMed ID: 19643608
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.
Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J
Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062
[TBL] [Abstract][Full Text] [Related]
20. Discovery of DA-1229: a potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes.
Kim HJ; Kwak WY; Min JP; Lee JY; Yoon TH; Kim HD; Shin CY; Kim MK; Choi SH; Kim HS; Yang EK; Cheong YH; Chae YN; Park KJ; Jang JM; Choi SJ; Son MH; Kim SH; Yoo M; Lee BJ
Bioorg Med Chem Lett; 2011 Jun; 21(12):3809-12. PubMed ID: 21570283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
